Covaxin Phase 1 Trial Clears Lancet Review - The Sikh Times
Politics

Covaxin Phase 1 Trial Clears Lancet Review

New Delhi: 22 Jan 21 Covaxin, India’s first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.Similar peer-reviewed studies for the Phase 2 are still awaited and Phase 3 trials are ongoing even as the government continues to give out the jabs to lakhs of front-line workers. While the first two phases of vaccine trials usually focus on their safety, the third stage generally determines its efficacy.

Related posts

Schools (in Delhi) are not likely to open,” Mr Sisodia”

thesikh

SC stays HC judgment that cancelled MP Navneet Kaur

thesikh

Ajit Pawar seeks PM Modi’s intervention in Maharashtra-Karnataka border issue

thesikh

CM Shanta Kumar taken to Mohali for COVID-19 treatment – Himachal

thesikh

Free Wi-Fi For Farmers Protesting At Delhi Border

thesikh

PM Modi Upset With BJP MPs For Skipping Parliament Session, Seeks List of Absentees

thesikh

Leave a Comment